Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

JAK inhibitors show promise for treating various skin diseases.

Naproxen can cause serious lung issues, but high-dose aspirin might be safer.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Bempikibart may help regrow hair in people with alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

EE/CMA is more effective than EE/LNG in reducing acne.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.